Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-01

Clinical Trial Update: Evaluation of The Efficacy And Safety of PD-1 + IL-2 Combined With Capox Treatment After Loop Colostomy Surgery in Left-sided Colorectal Cancer Patients Complicating Acute Obstruction [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating a PD-1 inhibitor plus interleukin-2 with Capecitabine/Oxaliplatin chemotherapy in left-sided colorectal cancer with acute ob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine (capecitabine)
  • Interleukin-2 (interleukin-2)
  • OXALIPLATIN (Oxaliplatin)
  • PD-1 inhibitor

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Left-sided Colorectal Cancer Complicating Acute Obstruction | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING